Малта - английски - Medicines Authority

renata pharmaceuticals (ireland) limited 13-18 city quay, dublin , dublin, d02ed70 , ireland - film-coated tablet - rivaroxaban 20 mg - antithrombotic agents

Ирландия - английски - HPRA (Health Products Regulatory Authority)

renata pharmaceuticals (ireland) limited - rivaroxaban - film-coated tablet - rivaroxaban

Ирландия - английски - HPRA (Health Products Regulatory Authority)

renata pharmaceuticals (ireland) limited - rivaroxaban - film-coated tablet - rivaroxaban

Малта - английски - Medicines Authority

renata pharmaceuticals (ireland) limited 13-18 city quay, dublin , dublin, d02ed70 , ireland - film-coated tablet - rivaroxaban 10 mg - antithrombotic agents

Ирландия - английски - HPRA (Health Products Regulatory Authority)

renata pharmaceuticals (ireland) limited - apixaban - film-coated tablet - apixaban

Ирландия - английски - HPRA (Health Products Regulatory Authority)

renata pharmaceuticals (ireland) limited - apixaban - film-coated tablet - apixaban

Ирландия - английски - HPRA (Health Products Regulatory Authority)

renata pharmaceuticals (ireland) limited - rivaroxaban - film-coated tablet - rivaroxaban

Австралия - английски - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - phenobarbital, quantity: 30 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; acacia; wheat starch - epilepsy; sedation

Австралия - английски - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - levetiracetam, quantity: 1000 mg - tablet, film coated - excipient ingredients: maize starch; colloidal anhydrous silica; croscarmellose sodium; povidone; microcrystalline cellulose; purified talc; magnesium stearate; titanium dioxide; macrogol 6000; polyvinyl alcohol; macrogol 3350 - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add-on therapy in the treatment of primary generalized tonic clonic (pgtc) seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).

Австралия - английски - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - levetiracetam, quantity: 500 mg - tablet, film coated - excipient ingredients: maize starch; colloidal anhydrous silica; croscarmellose sodium; povidone; microcrystalline cellulose; purified talc; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 6000; polyvinyl alcohol; macrogol 3350 - use in epileptic patients aged 4 years and older, initially as add-on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add-on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add-on therapy in the treatment of primary generalized tonic clonic (pgtc) seizures in adults and children from 4 years of age with idiopathic generalised epilepsy (ige).